The global POCT market was estimated at $13.87 billion in 2017 and is
estimated to grow over $23.92 billion by 2026.

The rise in the geriatric population along with the increased prevalence
of chronic diseases is expected to boost the demand for POCT devices and
drive growth of the global market. The POCT devices are portable, have
quick Turn Around Time (TAT) and are easy to use which makes them more
attractive for the end users, thereby increasing their demand and usage.

The global POCT market can be segmented based on product into devices,
consumables and software & other solutions. The major contributor to the
market in 2017 was the consumables/accessories segment. Based on the
application type, the market is segmented into blood glucose monitoring,
infectious diseases, blood gas & electrolytes, anticoagulant management,
pregnancy & fertility, substance abuse, urinalysis, cardiac markers,
lipids, HbA1C, tumor/cancer markers and others.

Based on the end users, the market can be segmented into hospitals,
clinics, homecare, diagnostic laboratories and others. The market for
the home care is expected to reach $5,740.2 million by 2026.
Geographically, the largest contributor to the growth of the global POCT
market in 2017 was North America due to the presence of supportive
governmental regulations and reimbursement policies apart from the
increase in the number of elderly people. This was followed by Europe.
The fastest growing region was Asia-pacific because of rising healthcare
expenditure and increasing patient awareness.

The PoC devices provide quick, efficient and safe detection method along
with the advantage of remote and confidential testing. The market is
expected to grow in the near future due to technological hybridization,
connectivity with smartphone-based applications, higher demand in the
developing nations, and increased usage across different indication.